neuroClues

Quelques mots pour décrire

In a world where neurological disorders will affect 1 person in 3 and where the number of Parkinson’s patients will double in the next decade, reaching 13 million patients, our mission is to empower clinicians with biomarkers allowing them to identify neurological disorders (Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis) years before visible symptoms.

Our goal is to support 10M patients by 2030.

Cette entreprise participe à l'initiative "Je choisis la French Tech"

NeuroClues

NeuroClues is a unique eye tracking solution integrating:
- an all-in-one portable laboratory performing high quality measurements (800 fps) and analysis (with FPGA) within a controlled environment and in an ecological/comfortable patient position.
- a frictionless software giving access to clinically relevant paradigms and providing science based biomarkers within minutes.
- an online cloud services to access, store and share data acquired with NeuroClues anywhere on any device and allowing to compare patients results over time and betwween patients across the world as the environment is standardized.

---